Renalytix (RENX) Competitors

Renalytix (LON:RENX) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, community ranking, risk, media sentiment and profitability.

Which has more volatility and risk, RENX or COG?

Renalytix has a beta of 1.92, suggesting that its stock price is 92% more volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500.

Which has preferable valuation and earnings, RENX or COG?

Cambridge Cognition has higher revenue and earnings than Renalytix. Cambridge Cognition is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Renalytix	£2.41M	14.77	-£41.85M	-£0.36	-82.47
Cambridge Cognition	£12.77M	1.40	-£3.74M	-£0.11	-466.36

Is RENX or COG more profitable?

Renalytix has a net margin of 0.00% compared to Cambridge Cognition's net margin of -29.25%. Cambridge Cognition's return on equity of -630.55% beat Renalytix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Renalytix	N/A	-651.40%	-88.32%
Cambridge Cognition	-29.25%	-630.55%	-13.31%

Do insiders & institutionals have more ownership in RENX or COG?

19.8% of Renalytix shares are held by institutional investors. Comparatively, 36.6% of Cambridge Cognition shares are held by institutional investors. 36.4% of Renalytix shares are held by insiders. Comparatively, 28.4% of Cambridge Cognition shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Does the MarketBeat Community believe in RENX or COG?

Cambridge Cognition received 82 more outperform votes than Renalytix when rated by MarketBeat users. However, 74.19% of users gave Renalytix an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.

Company	Underperform	Outperform
Renalytix	Outperform Votes 23 74.19%	Underperform Votes 8 25.81%
Cambridge Cognition	Outperform Votes 105 44.30%	Underperform Votes 132 55.70%

Do analysts rate RENX or COG?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Renalytix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the media prefer RENX or COG?

In the previous week, Cambridge Cognition had 4 more articles in the media than Renalytix. MarketBeat recorded 5 mentions for Cambridge Cognition and 1 mentions for Renalytix. Renalytix's average media sentiment score of 0.00 beat Cambridge Cognition's score of -0.19 indicating that Renalytix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Renalytix	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cambridge Cognition	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Cambridge Cognition beats Renalytix on 8 of the 15 factors compared between the two stocks.